Eribulin Mesylate
Written By Dr. Arpit Bhatnagar
Reviewed By Dr. Shilpa GarchaLast updated 27 Dec 2019 | 07:29 AM (UTC)
Eribulin Mesylate Uses
Eribulin Mesylate is used in the treatment of metastatic breast cancer. It is used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other anticancer medicines after the cancer has spread.
How Eribulin Mesylate works
Eribulin Mesylate is an anticancer medication. It works by interfering with the microtubule structures which help the cancer cells to divide and multiply. This slows the growth of cancer cells and eventually kills them.
Common side effects of Eribulin Mesylate
Anemia (low number of red blood cells), Decreased white blood cell count (neutrophils), Weakness, Tiredness, Hair loss, Nauseaasdfasd, Constipation
Want to Know More
Read Our Editorial PolicyMedicine brands for Eribulin Mesylate
Expert advice for Eribulin Mesylate
- Eribulin Mesylate helps treat breast cancer that has spread to other areas of the body.
- It is given by an injection into a vein (intravenously).
- It may cause dizziness and tiredness. Do not drive or do anything requiring concentration until you know how it affects you.
- Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for three months after you stop taking it.
- Your doctor may get regular blood tests done to monitor your blood cells and electrolyte levels during treatment with this medicine.
- Inform your doctor immediately if you notice any signs of infection such as fever, sore throat, rash or severe diarrhea while taking this medicine.
- It may cause numbness, tingling or pricking sensations in your hands and feet. Inform your doctor if this bothers you.